Toggle navigation
Home
Search
Services
Blog
Contact
About
Characterization of Newly Cloned Epithelial C1- Channel
Gordon, Eric A.
Mayo Clinic, Rochester, Rochester, MN, United States
Search 16 grants from Eric Gordon
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Elucidating a physiological role for ARRDC-1 Mediated Microvesicles (ARMMs): A versatile platform for the delivery of biological therapeutics
Obesity - Neural Control of Metabolism and Weight Gain
Molecular Analysis of Gastrointestinal Development
Thermodynamics of Binding in Respiratory Prote
Molecular Study of A Developmental Mutant
Recently added grants:
A Population Based Study of Ketorolac and Ovarian Cancer Survival
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
Neural Circuitry Mediating Behavioral Flexibility
Effects of marijuana use on inflammation and vascular injury in adults with HIV infection
Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL008922-01
Application #
2213756
Study Section
Clinical Trials (CLIN)
Project Start
1993-12-27
Project End
Budget Start
1993-06-29
Budget End
1994-06-28
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 1994
F32 HL
Newly Cloned Epithelial C1- Channel
Gordon, Eric A. / Mayo Clinic, Rochester
NIH 1993
F32 HL
Characterization of Newly Cloned Epithelial C1- Channel
Gordon, Eric A. / Mayo Clinic, Rochester
Publications
Flavin, T; Ivens, K; Wang, J et al.
(1991)
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
Transplant Proc 23:531-2
Comments
Be the first to comment on Eric Gordon's grant